Article Details

Syndax Pharmaceuticals (NASDAQ:SNDX) Downgraded to Hold at Zacks Investment Research

Retrieved on: 2018-10-05 09:08:59

Tags for this article:

Click the tags to see associated articles and topics

Syndax Pharmaceuticals (NASDAQ:SNDX) Downgraded to Hold at Zacks Investment Research. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc acquired a new stake in shares of Syndax Pharmaceuticals during the first quarter worth $173,000. Rhumbline Advisers ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo